Porosome Therapeutics, Inc.
Porosome-based drug delivery platform targeting intracellular transport mechanisms
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2021
- Latest Form D
- $1.5M, Sep 2023
- Total capital
- $1.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.8M
- 2 Form D · last Sep 2023
- 37 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1.5M
- Private capital raisedForm D · SEC · 1st filing$305K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Guillermo MarmolExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingFunctional Porosome ManipulationUSPTOApplication 19265874
- PendingAerosol And Topical Administration Of A Formulation Containing Cyclodextrin, Quercetin And Zinc, In Combination Or Separately, To Mitigate Infection By Enveloped VirusesUSPTOApplication 18680557
- PendingFunctional Porosome ManipulationUSPTOApplication 18584830
Show all 8 patent records
- Functional Porosome ManipulationNov 6, 2025 · Application 19265874Pending
- Aerosol And Topical Administration Of A Formulation Containing Cyclodextrin, Quercetin And Zinc, In Combination Or Separately, To Mitigate Infection By Enveloped VirusesSep 26, 2024 · Application 18680557Pending
- Functional Porosome ManipulationSep 26, 2024 · Application 18584830Pending
- Functional Porosome ManipulationFeb 15, 2024 · Application 18446111Pending
- Functional Porosome ManipulationApplication 63669321Pending
- Functional Porosome ManipulationApplication PCTUS2025037151Pending
- Extracellular Vesicle TreatmentApplication 63606357Pending
- Correction Of Alzheimer's Disease PathologyApplication 63751184Pending
Related companies, and why
- RS BioTherapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Solaxa Inc.Similar federal contract value in Biotech · null in contracts
- Rhinal Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- CRISPRQC INC.Similar federal contract value in Biotech · null in contracts
- BioFactura, Inc.Similar federal contract value in Biotech · null in contracts
- PNP THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .